| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Previous issue > Previous issue



Table of Contents | December, 2011  Vol. 43  No.4 Previous Issue | Next Issue | Archive
In this issue:



Review
205 Systems Biology Approaches to Decoding the Genome of Liver Cancer
Ju-Seog Lee, Ji Hoon Kim, Yun-Yong Park, Gordon B. Mills
Cancer Res Treat. 2011;43(4):205-211.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.205
                                 Cited By 3
Original Articles
212 Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment
Dal Yong Kim, Dae Ho Lee, Sun-Joo Jang, Sang-We Kim, Cheolwon Suh, Jung Shin Lee
Cancer Res Treat. 2011;43(4):212-216.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.212
                                 Cited By 1
217 Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis
Sang Hoon Chun, Ji Eun Lee, Mi Hee Park, Jin-Hyoung Kang, Young Kyoon Kim, Young-Pil Wang, Jae Kil Park, Hoon-Kyo Kim
Cancer Res Treat. 2011;43(4):217-224.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.217
                                 Cited By 2
225 A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis
Dong Hyun Lee, Sung Yong Oh, Yu Rim Lee, Seok Jae Huh, Hyun Hwa Yoon, Sung Hyun Kim, Suee Lee, Ji Hyun Lee, Young Kim, Hyo-Jin Kim, Hyuk-Chan Kwon
Cancer Res Treat. 2011;43(4):225-230.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.225
                                 Cited By 12
231 Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study
Paulo Rodrigues, Flavio O. Hering, Alex Meller
Cancer Res Treat. 2011;43(4):231-235.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.231
                                 Cited By 8
236 Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
Ji Soo Park, Jae Yun Lim, Seung Kyo Park, Min Kyung Kim, Hee Sung Ko, Sun Och Yoon, Jong Won Kim, Seung Ho Choi, Jae Yong Cho
Cancer Res Treat. 2011;43(4):236-243.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.236
                                 Cited By 11
244 Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases
Ji Yeon Kwon, Jina Yun, Han Jo Kim, Kyoung-Ha Kim, Se-Hyung Kim, Sang-Cheol Lee, Hyun Jung Kim, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu Taek Lee, Seong Kyu Park, Jong-Ho Won, Dae Sik Hong, Hee Sook Park
Cancer Res Treat. 2011;43(4):244-249.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.244
                                 Cited By 16
250 Expression of BamHI-A Rightward Transcripts in Epstein-Barr Virus-Associated Gastric Cancers
Bo-Gun Jang, Eun Ji Jung, Woo Ho Kim
Cancer Res Treat. 2011;43(4):250-254.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.250
                                 Cited By 8
Case Reports
255 Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation
Hye Ryun Jung, So Yeon Yun, Jun Hyeok Choi, Sung Hwa Bae, Hun-Mo Ryoo, Yoon-Seup Kum
Cancer Res Treat. 2011;43(4):255-259.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.255
                                 Cited By 8
260 Fatal Ifosfamide-Induced Metabolic Encephalopathy in Patients with Recurrent Epithelial Ovarian Cancer: Report of Two Cases
You-Jung Shin, Ji-Young Kim, Jei-Won Moon, Rae-Mi You, Jeong-Yeol Park, Joo-Hyun Nam
Cancer Res Treat. 2011;43(4):260-263.   Published online December 27, 2011    DOI: https://doi.org/10.4143/crt.2011.43.4.260
                                 Cited By 4
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Cancer Research and Treatment 2017; 49(4): 915-926.
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community